Last update
9/25/2025
Reviewed By
Overview
SCIENTIFIC SCORE
Questionable
Based on 6 Researches
6.5
USERS' SCORE
Moderately Good
Based on 17 Reviews
7.9
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Vitamin D3 (as cholecalciferol)
125 mcg
625%
Vitamin K activity from:Vitamin K1 (as phytonadione)Vitamin K2 (as menaquinone-4)Vitamin K2 (as trans menaquinone-7)
2,100 mcg1,000 mcg1,000 mcg100 mcg
1,750%
Iodine [from Sea-Iodine™ Complex Blend (organic kelp and bladderwrack extracts, potassium iodide)]
1,000 mcg
667%
Top Medical Research Studies
8
Vitamin D improves heart disease factors
We conducted a double-blind, randomized clinical trial to see how treating vitamin D deficiency could influence heart health, particularly in patients with ischemic heart disease (IHD). In our study, 44 IHD patients aged 40 to 65 were treated with either vitamin D or a placebo to assess changes in their lipid profiles and C-reactive protein (CRP) levels.
Our findings revealed that participants who received vitamin D supplementation showed notable improvements. Specifically, we observed higher levels of high-density lipoprotein cholesterol (HDL-C)—often referred to as the "good" cholesterol—and lower triglyceride levels among those treated with vitamin D. Interestingly, the increase in HDL-C and improvement in triglyceride levels underscore vitamin D’s potential role in enhancing lipid profiles in patients struggling with heart disease.
We also noted that vitamin D treatment didn’t significantly impact CRP levels, which are typically used as a marker for inflammation and heart disease risk. This suggests that while vitamin D might help improve certain lipids, its effects on other markers of heart disease need further investigation.
Overall, our study highlights the potential benefits of vitamin D supplementation as a tool to manage heart disease risk factors, offering a promising option for healthcare professionals working with patients suffering from IHD.
Our findings revealed that participants who received vitamin D supplementation showed notable improvements. Specifically, we observed higher levels of high-density lipoprotein cholesterol (HDL-C)—often referred to as the "good" cholesterol—and lower triglyceride levels among those treated with vitamin D. Interestingly, the increase in HDL-C and improvement in triglyceride levels underscore vitamin D’s potential role in enhancing lipid profiles in patients struggling with heart disease.
We also noted that vitamin D treatment didn’t significantly impact CRP levels, which are typically used as a marker for inflammation and heart disease risk. This suggests that while vitamin D might help improve certain lipids, its effects on other markers of heart disease need further investigation.
Overall, our study highlights the potential benefits of vitamin D supplementation as a tool to manage heart disease risk factors, offering a promising option for healthcare professionals working with patients suffering from IHD.
Read More
7
We explored the effects of vitamin D3 (VitD) on heart cells, focusing on its ability to counteract changes induced by angiotensin II (Ang II), a compound that can contribute to heart disease. The study involved exposing H9c2 cardiomyoblasts—heart muscle cells—to Ang II alone, and then to both Ang II and VitD to see how VitD might help.
Our findings revealed that while VitD effectively reduced the size of the cells and helped lower markers of hypertrophy (a condition where heart cells enlarge often due to strain), it did not significantly improve cell survival in the absence of a protein called sirtuin-1 (SIRT1). When SIRT1 was inhibited, VitD was unable to protect the cells as it normally would. This suggests that SIRT1 is crucial for the pro-survival benefits of vitamin D.
Importantly, while VitD showed promise in tackling hypertrophy, its protective effects rely heavily on SIRT1 being present. This could lead to new ideas for therapies in heart disease, where activating SIRT1 might enhance the benefits of vitamin D to improve heart health.
Our findings revealed that while VitD effectively reduced the size of the cells and helped lower markers of hypertrophy (a condition where heart cells enlarge often due to strain), it did not significantly improve cell survival in the absence of a protein called sirtuin-1 (SIRT1). When SIRT1 was inhibited, VitD was unable to protect the cells as it normally would. This suggests that SIRT1 is crucial for the pro-survival benefits of vitamin D.
Importantly, while VitD showed promise in tackling hypertrophy, its protective effects rely heavily on SIRT1 being present. This could lead to new ideas for therapies in heart disease, where activating SIRT1 might enhance the benefits of vitamin D to improve heart health.
Read More
3
We explored the connection between vitamin D levels and cardiovascular health in people with multiple sclerosis (pwMS). Specifically, our study examined the effects of vitamin D3 treatment on heart-related outcomes among patients with differing levels of vitamin D. Using data from 70 healthcare organizations over a period of five years, we focused on individuals who had either deficient or adequate vitamin D levels.
Our findings revealed that pwMS with deficient or inadequate vitamin D levels experienced an increased risk of major adverse cardiovascular events (MACE), including heart attacks and strokes. Importantly, while some pwMS received cholecalciferol (a form of vitamin D3) supplementation, this did not significantly reduce their risk of heart problems compared to those with adequate vitamin D levels who were not taking supplements.
Overall, our inquiry shows that simply having adequate vitamin D is crucial, but supplementation with vitamin D3 alone may not confer the expected cardiovascular protective benefits for pwMS. This suggests that more comprehensive strategies may be needed to address heart health in these patients.
Our findings revealed that pwMS with deficient or inadequate vitamin D levels experienced an increased risk of major adverse cardiovascular events (MACE), including heart attacks and strokes. Importantly, while some pwMS received cholecalciferol (a form of vitamin D3) supplementation, this did not significantly reduce their risk of heart problems compared to those with adequate vitamin D levels who were not taking supplements.
Overall, our inquiry shows that simply having adequate vitamin D is crucial, but supplementation with vitamin D3 alone may not confer the expected cardiovascular protective benefits for pwMS. This suggests that more comprehensive strategies may be needed to address heart health in these patients.
Read More
Most Useful Reviews
9
Effective vitamin combo
9 people found this helpful
Checked, it works. The combination of vitamins D and K is excellent. I feel superb after taking it with omega and vitamin C. During a recent illness, I found taking a loading dose along with vitamin C and zinc crucial; I experienced minimal symptoms. This product is just what I needed, and I appreciate its efficacy, so I encourage others to try it for their cardiovascular health.
Read More
9
Comprehensive support
7 people found this helpful
The D3-K and iodine combination is remarkable! Vitamin D is essential for the body's functioning beyond just bone health; it also impacts cardiovascular functions. Since my doctor advised that vitamin K is vital for effective calcium metabolism, this formula offers everything in one capsule. I'm pleased with the results, especially in improving cardiovascular health.
Read More
9
Universal health benefits
3 people found this helpful
This supplement is essential for everyone, given my experience as a trainer and nutritionist. My entire family has benefited, as well as my clients, with notable improvements in well-being and cardiovascular health. However, I advise against its use for those with thyroid or heart conditions.
Read More
Medical Researches
SCIENTIFIC SCORE
Questionable
Based on 6 Researches
6.5
- All Researches
8
Vitamin D improves heart disease factors
We conducted a double-blind, randomized clinical trial to see how treating vitamin D deficiency could influence heart health, particularly in patients with ischemic heart disease (IHD). In our study, 44 IHD patients aged 40 to 65 were treated with either vitamin D or a placebo to assess changes in their lipid profiles and C-reactive protein (CRP) levels.
Our findings revealed that participants who received vitamin D supplementation showed notable improvements. Specifically, we observed higher levels of high-density lipoprotein cholesterol (HDL-C)—often referred to as the "good" cholesterol—and lower triglyceride levels among those treated with vitamin D. Interestingly, the increase in HDL-C and improvement in triglyceride levels underscore vitamin D’s potential role in enhancing lipid profiles in patients struggling with heart disease.
We also noted that vitamin D treatment didn’t significantly impact CRP levels, which are typically used as a marker for inflammation and heart disease risk. This suggests that while vitamin D might help improve certain lipids, its effects on other markers of heart disease need further investigation.
Overall, our study highlights the potential benefits of vitamin D supplementation as a tool to manage heart disease risk factors, offering a promising option for healthcare professionals working with patients suffering from IHD.
Our findings revealed that participants who received vitamin D supplementation showed notable improvements. Specifically, we observed higher levels of high-density lipoprotein cholesterol (HDL-C)—often referred to as the "good" cholesterol—and lower triglyceride levels among those treated with vitamin D. Interestingly, the increase in HDL-C and improvement in triglyceride levels underscore vitamin D’s potential role in enhancing lipid profiles in patients struggling with heart disease.
We also noted that vitamin D treatment didn’t significantly impact CRP levels, which are typically used as a marker for inflammation and heart disease risk. This suggests that while vitamin D might help improve certain lipids, its effects on other markers of heart disease need further investigation.
Overall, our study highlights the potential benefits of vitamin D supplementation as a tool to manage heart disease risk factors, offering a promising option for healthcare professionals working with patients suffering from IHD.
Read More
7
We explored how different vitamin D treatments may influence cardiovascular disease (CVD) risk among patients with chronic kidney disease (CKD). Our observational study included 83 CKD patients who were treated with vitamin D or its analogs and had varying histories of CVD. By measuring the thickness of perirenal adipose tissue (PAT) and assessing clinical parameters, we aimed to uncover any links between vitamin D treatment and cardiovascular health.
We found that patients with a history of CVD showed thicker PAT compared to those without such a history. Interestingly, our comparisons among patients receiving different forms of vitamin D revealed that those treated with paricalcitol had less PAT accumulation than those on cholecalciferol or calcitriol. This suggests that the type of vitamin D treatment may play a role in managing CVD risk in CKD patients.
Although our findings indicate differences in PAT thickness related to vitamin D treatment, we did not conduct a controlled trial that would allow us to claim a definitive benefit of vitamin D3 alone on cardiovascular health. It appears that further investigation is necessary to clarify these relationships and understand the mechanisms at play.
We found that patients with a history of CVD showed thicker PAT compared to those without such a history. Interestingly, our comparisons among patients receiving different forms of vitamin D revealed that those treated with paricalcitol had less PAT accumulation than those on cholecalciferol or calcitriol. This suggests that the type of vitamin D treatment may play a role in managing CVD risk in CKD patients.
Although our findings indicate differences in PAT thickness related to vitamin D treatment, we did not conduct a controlled trial that would allow us to claim a definitive benefit of vitamin D3 alone on cardiovascular health. It appears that further investigation is necessary to clarify these relationships and understand the mechanisms at play.
Read More
7
We explored the effects of vitamin D3 (VitD) on heart cells, focusing on its ability to counteract changes induced by angiotensin II (Ang II), a compound that can contribute to heart disease. The study involved exposing H9c2 cardiomyoblasts—heart muscle cells—to Ang II alone, and then to both Ang II and VitD to see how VitD might help.
Our findings revealed that while VitD effectively reduced the size of the cells and helped lower markers of hypertrophy (a condition where heart cells enlarge often due to strain), it did not significantly improve cell survival in the absence of a protein called sirtuin-1 (SIRT1). When SIRT1 was inhibited, VitD was unable to protect the cells as it normally would. This suggests that SIRT1 is crucial for the pro-survival benefits of vitamin D.
Importantly, while VitD showed promise in tackling hypertrophy, its protective effects rely heavily on SIRT1 being present. This could lead to new ideas for therapies in heart disease, where activating SIRT1 might enhance the benefits of vitamin D to improve heart health.
Our findings revealed that while VitD effectively reduced the size of the cells and helped lower markers of hypertrophy (a condition where heart cells enlarge often due to strain), it did not significantly improve cell survival in the absence of a protein called sirtuin-1 (SIRT1). When SIRT1 was inhibited, VitD was unable to protect the cells as it normally would. This suggests that SIRT1 is crucial for the pro-survival benefits of vitamin D.
Importantly, while VitD showed promise in tackling hypertrophy, its protective effects rely heavily on SIRT1 being present. This could lead to new ideas for therapies in heart disease, where activating SIRT1 might enhance the benefits of vitamin D to improve heart health.
Read More
7
In exploring how vitamin D3 influences cardiovascular disease, we conducted experiments with both young and aged mice, who were treated with vitamin D3 or saline to assess its impact on vascular calcification. Out of our findings, it was crucial to note that while vitamin D3 treatments were utilized, we also incorporated Elabela and other compounds, making it challenging to isolate vitamin D3's specific effects on cardiovascular health fully.
Through our study, we observed the potential protective role of Elabela against vascular calcification, particularly acting through pathways that involve PPAR-γ and FDX1 signaling. However, the combination of treatments lacks clarity on the specific benefits of vitamin D3 by itself in managing vascular health. Thus, the data does not present a clear advantage for vitamin D3 in reducing cardiovascular disease risks when considered independently from Elabela.
Overall, our research underlines the complexity of vitamin D3's role in cardiovascular conditions and indicates that more targeted studies are necessary to define its specific contributions clearly.
Through our study, we observed the potential protective role of Elabela against vascular calcification, particularly acting through pathways that involve PPAR-γ and FDX1 signaling. However, the combination of treatments lacks clarity on the specific benefits of vitamin D3 by itself in managing vascular health. Thus, the data does not present a clear advantage for vitamin D3 in reducing cardiovascular disease risks when considered independently from Elabela.
Overall, our research underlines the complexity of vitamin D3's role in cardiovascular conditions and indicates that more targeted studies are necessary to define its specific contributions clearly.
Read More
7
We explored how serum levels of vitamin D3, specifically 25(OH)D, might influence various indicators related to cardiovascular health. Using data from the National Health and Nutrition Examination Survey (NHANES) spanning 2015 to 2018, we analyzed results from 4,727 adults aged 20 and above.
Our investigation focused on several key factors such as body mass index, high-density lipoprotein cholesterol, systolic blood pressure, and cholesterol levels. The results showed that even a slight increase in vitamin D3 levels was associated with positive changes across these cardiovascular risk factors. For instance, we found that a 1 nmol/L increase in serum 25(OH)D led to small but significant improvements in several indicators.
Notably, the effects varied by gender and age, with women showing greater sensitivity to vitamin D3 levels compared to men, while older adults were less responsive. However, our findings highlighted a complex relationship, revealing nonlinear patterns that suggest additional research is necessary to fully understand these dynamics. While the results display promising associations, they do not confirm that vitamin D3 treatment can directly improve cardiovascular disease outcomes.
Our investigation focused on several key factors such as body mass index, high-density lipoprotein cholesterol, systolic blood pressure, and cholesterol levels. The results showed that even a slight increase in vitamin D3 levels was associated with positive changes across these cardiovascular risk factors. For instance, we found that a 1 nmol/L increase in serum 25(OH)D led to small but significant improvements in several indicators.
Notably, the effects varied by gender and age, with women showing greater sensitivity to vitamin D3 levels compared to men, while older adults were less responsive. However, our findings highlighted a complex relationship, revealing nonlinear patterns that suggest additional research is necessary to fully understand these dynamics. While the results display promising associations, they do not confirm that vitamin D3 treatment can directly improve cardiovascular disease outcomes.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 17 Reviews
7.9
- All Reviews
- Positive Reviews
- Negative Reviews
9
Effective vitamin combo
9 people found this helpful
Checked, it works. The combination of vitamins D and K is excellent. I feel superb after taking it with omega and vitamin C. During a recent illness, I found taking a loading dose along with vitamin C and zinc crucial; I experienced minimal symptoms. This product is just what I needed, and I appreciate its efficacy, so I encourage others to try it for their cardiovascular health.
Read More
9
Comprehensive support
7 people found this helpful
The D3-K and iodine combination is remarkable! Vitamin D is essential for the body's functioning beyond just bone health; it also impacts cardiovascular functions. Since my doctor advised that vitamin K is vital for effective calcium metabolism, this formula offers everything in one capsule. I'm pleased with the results, especially in improving cardiovascular health.
Read More
9
Universal health benefits
3 people found this helpful
This supplement is essential for everyone, given my experience as a trainer and nutritionist. My entire family has benefited, as well as my clients, with notable improvements in well-being and cardiovascular health. However, I advise against its use for those with thyroid or heart conditions.
Read More
9
Effective composition
I started this supplement due to calcium affecting my cardiovascular system. It effectively directs calcium to my bones and protects my blood vessels. I highly recommend it, especially in areas with limited sunlight.
Read More
9
Cognitive health support
This formula provides essential nutrients: 125 mcg Vitamin D3, 2100 mcg Vitamin K, and 1000 mcg iodine, supporting cardiovascular disease and cognitive health. Maintaining healthy vitamin levels is vital for bone density and overall well-being.
Read More
Frequently Asked Questions
7.5
Improved cardiovascular health
210 people found this helpful
In particular, with severe osteoporosis and blood clotting issues, I noticed significant improvements in my overall state in a short time. By the second day, bleeding frequency reduced drastically, and joint pain diminished enough for less reliance on painkillers. After a month, my condition was vastly better. The capsules are small, with an excellent composition. Vitamin K enhances vitamin D absorption, which is vital for my health, given the Ural climate's lack of sun.
7.5
Calcium absorption support
1 people found this helpful
Due to age, it’s necessary to supplement calcium with vitamins D and K to direct calcium to the bones and prevent issues related to cardiovascular disease. This product conveniently delivers all necessary nutrients, including iodine, for overall health.
9
Effective composition
I started this supplement due to calcium affecting my cardiovascular system. It effectively directs calcium to my bones and protects my blood vessels. I highly recommend it, especially in areas with limited sunlight.
7.5
Well-rounded support
1 people found this helpful
I found this to be effective for my bone, immune, and cardiovascular health. The combination of various forms of vitamin K2 makes this a well-rounded supplement. I advise consulting a healthcare professional beforehand since not everyone may require high doses.
9
Universal health benefits
3 people found this helpful
This supplement is essential for everyone, given my experience as a trainer and nutritionist. My entire family has benefited, as well as my clients, with notable improvements in well-being and cardiovascular health. However, I advise against its use for those with thyroid or heart conditions.
7.5
Strengthens cardiovascular system
2 people found this helpful
The three-in-one product format is convenient, combining vitamins D and K, along with iodine. It effectively supports bone and gland health, helping prevent thyroid disease due to iodine deficiency. The quality is excellent, and it contributes remarkably to my cardiovascular strength.
9
Effective vitamin combo
9 people found this helpful
Checked, it works. The combination of vitamins D and K is excellent. I feel superb after taking it with omega and vitamin C. During a recent illness, I found taking a loading dose along with vitamin C and zinc crucial; I experienced minimal symptoms. This product is just what I needed, and I appreciate its efficacy, so I encourage others to try it for their cardiovascular health.
7.5
Bone health improvement
11 people found this helpful
I take Vitamin K2 with Vitamin D3 to ensure calcium is absorbed in my bones rather than in soft tissues, which protects against cardiovascular disease. Despite doctors often neglecting K2, its benefits, such as reducing fracture risk, are significant.
9
Supports immune health
1 people found this helpful
Vitamin D-3 is critical for immune support. If you're not in a sunny area, supplementation is often necessary, and I take 5000 IU. Remember to take Magnesium and Vitamin K2 alongside, as they work together for cardiovascular disease treatment.
9
Cognitive health support
This formula provides essential nutrients: 125 mcg Vitamin D3, 2100 mcg Vitamin K, and 1000 mcg iodine, supporting cardiovascular disease and cognitive health. Maintaining healthy vitamin levels is vital for bone density and overall well-being.
7
We explored how serum levels of vitamin D3, specifically 25(OH)D, might influence various indicators related to cardiovascular health. Using data from the National Health and Nutrition Examination Survey (NHANES) spanning 2015 to 2018, we analyzed results from 4,727 adults aged 20 and above.
Our investigation focused on several key factors such as body mass index, high-density lipoprotein cholesterol, systolic blood pressure, and cholesterol levels. The results showed that even a slight increase in vitamin D3 levels was associated with positive changes across these cardiovascular risk factors. For instance, we found that a 1 nmol/L increase in serum 25(OH)D led to small but significant improvements in several indicators.
Notably, the effects varied by gender and age, with women showing greater sensitivity to vitamin D3 levels compared to men, while older adults were less responsive. However, our findings highlighted a complex relationship, revealing nonlinear patterns that suggest additional research is necessary to fully understand these dynamics. While the results display promising associations, they do not confirm that vitamin D3 treatment can directly improve cardiovascular disease outcomes.
Our investigation focused on several key factors such as body mass index, high-density lipoprotein cholesterol, systolic blood pressure, and cholesterol levels. The results showed that even a slight increase in vitamin D3 levels was associated with positive changes across these cardiovascular risk factors. For instance, we found that a 1 nmol/L increase in serum 25(OH)D led to small but significant improvements in several indicators.
Notably, the effects varied by gender and age, with women showing greater sensitivity to vitamin D3 levels compared to men, while older adults were less responsive. However, our findings highlighted a complex relationship, revealing nonlinear patterns that suggest additional research is necessary to fully understand these dynamics. While the results display promising associations, they do not confirm that vitamin D3 treatment can directly improve cardiovascular disease outcomes.
7
We explored the effects of vitamin D3 (VitD) on heart cells, focusing on its ability to counteract changes induced by angiotensin II (Ang II), a compound that can contribute to heart disease. The study involved exposing H9c2 cardiomyoblasts—heart muscle cells—to Ang II alone, and then to both Ang II and VitD to see how VitD might help.
Our findings revealed that while VitD effectively reduced the size of the cells and helped lower markers of hypertrophy (a condition where heart cells enlarge often due to strain), it did not significantly improve cell survival in the absence of a protein called sirtuin-1 (SIRT1). When SIRT1 was inhibited, VitD was unable to protect the cells as it normally would. This suggests that SIRT1 is crucial for the pro-survival benefits of vitamin D.
Importantly, while VitD showed promise in tackling hypertrophy, its protective effects rely heavily on SIRT1 being present. This could lead to new ideas for therapies in heart disease, where activating SIRT1 might enhance the benefits of vitamin D to improve heart health.
Our findings revealed that while VitD effectively reduced the size of the cells and helped lower markers of hypertrophy (a condition where heart cells enlarge often due to strain), it did not significantly improve cell survival in the absence of a protein called sirtuin-1 (SIRT1). When SIRT1 was inhibited, VitD was unable to protect the cells as it normally would. This suggests that SIRT1 is crucial for the pro-survival benefits of vitamin D.
Importantly, while VitD showed promise in tackling hypertrophy, its protective effects rely heavily on SIRT1 being present. This could lead to new ideas for therapies in heart disease, where activating SIRT1 might enhance the benefits of vitamin D to improve heart health.
3
We explored the connection between vitamin D levels and cardiovascular health in people with multiple sclerosis (pwMS). Specifically, our study examined the effects of vitamin D3 treatment on heart-related outcomes among patients with differing levels of vitamin D. Using data from 70 healthcare organizations over a period of five years, we focused on individuals who had either deficient or adequate vitamin D levels.
Our findings revealed that pwMS with deficient or inadequate vitamin D levels experienced an increased risk of major adverse cardiovascular events (MACE), including heart attacks and strokes. Importantly, while some pwMS received cholecalciferol (a form of vitamin D3) supplementation, this did not significantly reduce their risk of heart problems compared to those with adequate vitamin D levels who were not taking supplements.
Overall, our inquiry shows that simply having adequate vitamin D is crucial, but supplementation with vitamin D3 alone may not confer the expected cardiovascular protective benefits for pwMS. This suggests that more comprehensive strategies may be needed to address heart health in these patients.
Our findings revealed that pwMS with deficient or inadequate vitamin D levels experienced an increased risk of major adverse cardiovascular events (MACE), including heart attacks and strokes. Importantly, while some pwMS received cholecalciferol (a form of vitamin D3) supplementation, this did not significantly reduce their risk of heart problems compared to those with adequate vitamin D levels who were not taking supplements.
Overall, our inquiry shows that simply having adequate vitamin D is crucial, but supplementation with vitamin D3 alone may not confer the expected cardiovascular protective benefits for pwMS. This suggests that more comprehensive strategies may be needed to address heart health in these patients.
References
- Checa-Ros A, Locascio A, Okojie OJ, Abellán-Galiana P, D'Marco L. Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study. BMC Nephrol. 2025;26:119. 10.1186/s12882-025-04041-2
- Astani A, Maroofi A, Hekmatimoghaddam S, Sarebanhassanabadi M, Safari F. Sirtuin 1 mediates the pro-survival effects of vitamin D in angiotensin II-induced hypertrophy of H9c2 cardiomyoblasts. Mol Biol Rep. 2024;52:96. 10.1007/s11033-024-10168-6
- Qi RQ, Chen YF, Cheng J, Song JW, Chen YH, et al. Elabela alleviates cuproptosis and vascular calcification in vitaminD3- overloaded mice via regulation of the PPAR-γ /FDX1 signaling. Mol Med. 2024;30:223. 10.1186/s10020-024-00997-3
- France-Ratcliffe M, Harrison SL, Verma LA, Abdul-Rahim AH, McCallum L, et al. Vitamin D and cardiovascular outcomes in multiple sclerosis. Mult Scler Relat Disord. 2024;92:106155. 10.1016/j.msard.2024.106155
- Sadeghi M, Momeni A, Mirsaeidi FS, Jamalian M, Amirpour A, et al. The Effect of Vitamin D Deficiency Treatment on Lipid Profile and C-reactive Protein in Patients with Ischemic Heart Disease: Double-blind Randomized Clinical Trial. Adv Biomed Res. 2024;13:79. 10.4103/abr.abr_380_23
- Pan YX, Fu YC, Chen H, Zhao MY. [Association of serum 25(OH)D with cardiovascular risk-related indicators: cross-sectional analysis of NHANES]. Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58:1388. 10.3760/cma.j.cn112150-20240519-00403
